Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2000
10/26/2000WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/26/2000WO2000062735A2 Treatment of neoplasms with viruses
10/26/2000WO2000062657A2 Improvement of t cell mediated immunity
10/26/2000WO2000062614A1 Therapeutic mixture useful in inhibiting lesion formation after vascular injury
10/26/2000WO2000062605A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING
10/26/2000WO2000047607B1 A synthetic peptide disturbing intracellular signaling
10/26/2000WO2000040719A3 Tissue repair protein involved in orofacial clefting and uses thereof
10/26/2000WO2000037099A3 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
10/26/2000WO2000036089A3 Methods of immunosuppression
10/26/2000WO2000035481A3 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
10/26/2000WO2000034465A3 HEAT SHOCK GENES AND PROTEINS FROM NEISSERIA MENINGITIDIS, CANDIDA GLABRATA AND $i(ASPERGILLUS FUMIGATUS)
10/26/2000WO2000034315A8 Purification of echinocandin cyclopeptide compounds
10/26/2000WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1')
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000028045A3 Human hydrolase proteins
10/26/2000WO2000027873A9 Interleukin-2 binding protein from arthropods
10/26/2000WO2000025808A8 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
10/26/2000WO2000024770A9 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
10/26/2000WO2000018922A3 Human carbohydrate-associated proteins
10/26/2000WO2000018795A3 Compositions and methods for wt1 specific immunotherapy
10/26/2000WO2000016801A9 Methods of downmodulating the immune response to therapeutic proteins
10/26/2000WO2000006206A9 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/26/2000DE19919308A1 Antipsoriatic composition containing proteolytic enzyme, preferably bromelain, removes harmful metabolites from epidermal basal layer cells to normalize skin structure
10/26/2000DE19918682A1 New recombinant DNA encoding an allergen produced by grasses of the Poaceae family, useful for diagnosis of pollen allergy and for treatment by desensitization
10/26/2000CA2758956A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000CA2373359A1 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000CA2371976A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
10/26/2000CA2371942A1 Pseudomycin antifungal compositions and methods for their use
10/26/2000CA2371611A1 Galectin 11
10/26/2000CA2371399A1 Skin care compositions containing combination of skin care actives
10/26/2000CA2371363A1 Antifungal agents isolated from pseudomonas syringae
10/26/2000CA2370690A1 Cationic peg-lipids and methods of use
10/26/2000CA2370659A1 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000CA2370628A1 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000CA2370609A1 Adipocyte complement related protein homolog zacrp3
10/26/2000CA2370602A1 Adipocyte complement related protein homolog zacrp2
10/26/2000CA2370521A1 Streptokinase fragments and their use for inhibiting cell death
10/26/2000CA2370301A1 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000CA2370296A1 Improvement of t cell mediated immunity
10/26/2000CA2370259A1 Pyrrolidincarbonylamino cyclic disulfides
10/26/2000CA2370246A1 Vascular endothelial cell growth factor variants and uses thereof
10/26/2000CA2370239A1 Pseudomycin production by pseudomonas syringae
10/26/2000CA2370197A1 Methods for regulating the condition of mammalian keratinous tissue
10/26/2000CA2370142A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2369961A1 Polypeptides derived from endostatin exhibiting antiangiogenic activity
10/26/2000CA2369820A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000CA2369808A1 Process for microencapsulation of water soluble substances
10/26/2000CA2369772A1 A therapeutic mixture useful in inhibiting lesion formation after vascular injury
10/26/2000CA2369764A1 Enos mutations useful for gene therapy and therapeutic screening
10/26/2000CA2369762A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000CA2369342A1 Carbohydrate-modifying enzymes
10/26/2000CA2369136A1 Pseudomycin natural products
10/26/2000CA2369078A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000CA2368839A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000CA2368784A1 Methods of treating clinical diseases with isoflavones
10/26/2000CA2368590A1 Human hac3
10/26/2000CA2365949A1 Adhesion modulatory peptides and methods for use
10/26/2000CA2365523A1 Identification of sortase gene
10/26/2000CA2365449A1 Inhibitor of the growth of androgen-independent tumor
10/26/2000CA2365434A1 Angiogenic growth factors for treatment of peripheral neuropathy
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2330231A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000CA2330022A1 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/25/2000EP1046715A1 Interaction of vascular-endothelial protein-tyrosine phosphatase with the angiopoietin receptor tie-2
10/25/2000EP1046711A2 Recombinant adeno-associated virus
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046651A1 Composition and method for modulating dendritic cell-T interaction
10/25/2000EP1046400A1 Methods and compositions for treating human cells
10/25/2000EP1046399A1 HCV combination therapy, containing ribavirin in association with antioxidants
10/25/2000EP1045926A2 Gene family with transformation modulating activity
10/25/2000EP1045920A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy
10/25/2000EP1045913A2 Human protease molecules
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP1045907A1 Dkr polypeptides
10/25/2000EP1045906A1 Apo-2 ligand
10/25/2000EP1045901A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4
10/25/2000EP1045862A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
10/25/2000EP1045861A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand
10/25/2000EP1045860A2 Methods and compositions for treating and diagnosing insulin related disorders
10/25/2000EP1045859A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)
10/25/2000EP1045858A1 Anti-cryptococcal peptides
10/25/2000EP1045709A1 Method and device for in-situ formulation of a medicinal solution for parenteral application
10/25/2000EP1045701A1 Methods of using human receptor protein 4-1bb
10/25/2000EP1045699A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle
10/25/2000EP1045697A2 Extension of cellular lifespan, methods and reagents
10/25/2000EP1045676A1 Intravascular apparatus and method
10/25/2000EP1045635A1 Cloning using donor nuclei from differentiated fetal and adult cells
10/25/2000EP0804088B1 Stabilized composition comprising colistin sulfate
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000EP0736039B1 Compounds with growth hormone releasing properties
10/25/2000EP0649603B1 Antioxidant food, antioxidant preparation and antioxidization method
10/25/2000EP0627911B1 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
10/25/2000EP0601053B1 Compositions and methods for the sublingual or buccal administration of therapeutic agents
10/25/2000CN1271391A Methods and compositions for therapies using genges encoding secreted proteins such as interferon-beta
10/25/2000CN1271387A Mammalian cytokine: interleukin-B30 and related reagents
10/25/2000CN1271386A Amino-terminally trancated RANTES as chemokine antagonists
10/25/2000CN1271385A Amino-terminally truncated MCP-2 as chemokine antagnosits
10/25/2000CN1271365A Compounds with anti-KS and anti-HIV activity
10/25/2000CN1271292A Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
1 ... 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 ... 3163